Latest news with #Spectral


Scotsman
7 days ago
- Entertainment
- Scotsman
Hidden Door Festival, Edinburgh review: 'a welcome return'
Sign up to our Arts and Culture newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Hidden Door, The Paper Factory, Edinburgh ★★★★★ 'We played here in November and it was minus twelve degrees and we couldn't feel our fingers, but it was already pretty good,' said Glasgow art-punks Brenda on Saturday night, as the trio – a flurry of sharp melodies and hot sarcasm in boiler suits and red PVC – delivered one of the many highlight sets of a weekend marking the welcome return of Edinburgh's Hidden Door festival. It's a sign of the developer era that the festival's original calling to occupy and celebrate disused and derelict spaces and turn them into one-week music and arts festivals is increasingly drawing a blank on undeveloped sites in central Edinburgh. The Paper Factory – the former Saica paper and cardboard factory by Gogar roundabout – is on the city's far western edge, behind the Edinburgh Gateway tram/train interchange and in view of Edinburgh Airport's control tower. One day soon it too will be demolished, consumed by the sprawl of Scotland's capital. Advertisement Hide Ad Advertisement Hide Ad Tinderbox Orchestra at Hidden Door For a few days, however, it was a site of pilgrimage. Much of what happened on the Friday and Saturday reflected the building's heritage, from Jill Martin Boualaxai's festival-commissioned performance art piece Ghost in the Machine, a gestural physical work performed in and around a piece of illuminated plant machinery, its shell being hammered on by Edinburgh's reactivated Sativa Drummers, to the group work we have all been here – now into the light. The latter featured an installation in the cluttered workers' locker room featuring a stark electronic soundtrack and headphone interviews with former factory workers, a ghost memory of what used to take place here. Elsewhere in the vast space dubbed the 'Factory Floor', meanwhile, the Sativa Drummers reemerged on Saturday night to carry out their own thundering dancefloor performance, recreating the sound of industry as music for dance and catharsis. Other art, meanwhile, just sat beautifully in the space without responding much to it at all, for example Abby Warlow and Lewis Gourlay's vaulting, ceiling-height films of figures dancing, or Juliana Capes' captivating Rainbow Pods, a cascade of multicoloured balls caught in motion in mid-flow from the ceiling. Advertisement Hide Ad Advertisement Hide Ad Alice Faye at Hidden Door PIC: Dan Mosley for Hidden Door Most spectacular of all, the Crane Shed hosted another commissioned work, choreographer Tess Letham's dance piece Spectral, with four female figures, two grounded and two spinning on aerial wires, filling this vast space to clubby music and lighting arrangements by Dave House and Sam Jones. There was also great music, and lots of it, across two large rooms perfectly reimagined as concert spaces; emerging singer-songwriter Alice Faye; the spiky, stylish beat-pop of PVC; the driving, heartfelt Americana of Katy J Pearson; the sheer catharsis of Tinderbox Orchestra, their joyous, semi-synchronised dance moves providing a self-professed antidote to the fearmongering of the moment; and the brilliant Voka Gentle, who cycled through spiky New Wave, dirty glam and gorgeous, understated lyricism.


Tom's Guide
11-06-2025
- Entertainment
- Tom's Guide
3 best Netflix action movies you (probably) haven't seen
From "Havoc" to "Bullet Train Explosion" to "Exterritorial", Netflix is chock-full of high-octane action movies to get your pulse pumping and your energy up. However, the sheer breadth of options available on that top-rate streaming service — especially when it comes to the streamer's original content — can make it easier said than done when narrowing that selection down to one quality action-packed flick. So we've made things a bit easier for you by spotlighting a trio of action movies that you might've missed the first time around. These underrated Netflix titles range from a French action thriller about a skilled female soldier who seeks out revenge for crimes against her family, to a gory and guns-blazing South Korean film about a bodyguard-turned-assassin. If it's fast-paced chase sequences, bloody fight scenes, expert stunt work and fiery explosions you're after, here are three Netflix action movies you (probably) haven't seen yet but definitely should. When it comes to action movies, nothing tastes quite as sweet as revenge — and Jang Ok-ju (played by "The Call" star Jeon Jong-seo), a former bodyguard for elite VIP clients, is out for just that after her best friend Choi Min-hee (Park Yu-rim) commits suicide and leaves behind a final wish of getting vengeance against Choi Pro (Kim Ji-hoon), the sex trafficker who abused and extorted her. Ok-ju tracks down Choi's address and sets off to brutally do her dearly departed friend's bidding. Written and directed by Lee Chung-hyun, "Ballerina" (not to be confused with the recent "John Wick" spinoff) has a 91% approval rating on Rotten Tomatoes and pulled in 14.7 million views and 23.1 million hours of viewing when it debuted on Netflix in October 2023, earning it the number one spot in Netflix's top 10 list of most-watched non-English films. Rohan Naahar of The Indian Express wrote of the "bone-crushing" thriller: "Neon visuals and a thumping soundtrack elevate Netflix's slickly packaged Korean revenge thriller that substitutes plot in favour of pure vibes." Watch "Ballerina" on Netflix now Get instant access to breaking news, the hottest reviews, great deals and helpful tips. Written and directed by Nic Mathieur, this 2016 sci-fi action flick is set in a civil war-ridden Moldova, where US forces have been engaging insurgents of the former regime—that is, until a new threat emerges: an invisible and unknown entity that kills almost instantaneously any living being caught in its path. Leading the special-ops team dispatched to fight the supernatural beings is James Badge Dale as DARPA scientist Mark Clyne; Emily Mortimer also stars as CIA officer Fran Madison, with Max Martini, Bruce Greenwood and Clayne Crawford in supporting roles. Over on Pajiba, Jodi Smith writes of the film: "Instead of going for huge stars, awkward and unneeded backstories, and bloat, 'Spectral' manages to pack in just what a viewer needs to enjoy the plot and journey placed before them." Watch "Spectral" on Netflix now Dubbed "John Wick on the Riviera" by Vulture critic Bilge Ebiri, the Julien Leclercq-directed "Sentinelle" centers on Klara (Olga Kurylenko), a highly-trained French soldier who has returned home to Nice from serving in the Middle East traumatized by the harrowing experience. But unfortunately, the hits keep coming for Klara. After her sister Tania (Marilyn Lima) is horrifically raped and left in a coma, Klara users her lethal military skills to hunt down the men who hurt her sibling. Though some critics have pointed out that the lean-and-mean script (co-written by Leclercq and Matthieu Serveau) suffers from some cliches, Decider reviewer Johnny Loftus praises the action movie for balancing "its beats of emotional trauma against the darker forces of vigilantism," adding that the film "doesn't forgive its main character's drastic actions, but it illustrates pretty well how she got there." Watch "Sentinelle" on Netflix now
Yahoo
06-06-2025
- Business
- Yahoo
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual Meeting of shareholders (the "Shareholders") held yesterday on June 5, 2025 (the "Meeting"). The Company confirms that all resolutions put forward in the Management Information Circular dated April 17, 2025 (the "Circular") to its Shareholders were approved. Results of the matters voted on at the Meeting are set out below. Election of Directors Spectral's seven director nominees were elected: Nominee Votes For (percent) Votes Withheld (percent) Jan D'Alvise 99.78% 0.22% Jun Hayakawa 99.79% 0.21% Chris Seto 89.39% 10.61% William Stevens 99.50% 0.50% Paul Walker 97.67% 2.33% David W. Feigal, Jr. 99.67% 0.33% Cristiano Franzi 99.78% 0.22% Appointment of Auditors MNP LLP, Chartered Accountants, was re-appointed as auditor of Spectral. Votes For: 99.95% Votes Withheld: 0.05% About Spectral Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ ('PMX'). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company's FDA cleared Endotoxin Activity Assay (EAA™), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively over 360,000 times to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America each year. The Tigris Trial is a confirmatory study of PMX in addition to standard care vs standard care alone and is designed as a 2:1 randomized trial of 150 patients using Bayesian statistics. Endotoxic septic shock is a malignant form of sepsis The trial methods are detailed in 'Bayesian methods: a potential path forward for sepsis trials'. Spectral is listed on the Toronto Stock Exchange under the symbol EDT. For more information, please visit statement Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of Spectral and anticipated events or results, are assumptions based on beliefs of Spectral's senior management as well as information currently available to it. While these assumptions were considered reasonable by Spectral at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the company's ability to raise capital and the availability of funds and resources to pursue R&D projects, the recruitment of additional clinical trial sites, the rate of patient enrollment, the successful and timely completion of clinical studies, the success of Baxter's commercialization efforts, the ability of Spectral to take advantage of business opportunities in the biomedical industry, the granting of necessary approvals by regulatory authorities as well as general economic, market and business conditions, and could differ materially from what is currently expected. The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement. For further information, please contact: Ali MahdaviCapital Markets & Investor RelationsSpinnaker Capital Markets Inc.416-962-3300am@

Associated Press
03-06-2025
- Business
- Associated Press
Spectral Capital Corporation Outlines Significant Business Upgrades Ahead of Planned NASDAQ Up-listing
SEATTLE, June 3, 2025 /PRNewswire/ -- Spectral Capital Corporation (OTC: FCCN) today announced a series of major corporate upgrades and strategic initiatives as it prepares for an up-listing to the Nasdaq Stock Market. These developments, spanning corporate governance, technological collaboration, and growth strategy, are designed to strengthen Spectral's foundation and accelerate its momentum toward high-growth and innovation. Key Initiatives Underway Include: Enhanced Board Governance: Appointment of new independent directors and formation of formal Audit and Corporate Governance committees to meet higher exchange standards. This move bolsters oversight and aligns the Company's governance with Nasdaq's rigorous requirements. World-Class Board Expertise: Invitations extended to distinguished luminaries in technology and science – including two Nobel Prize laureates – to join Spectral's Board of Directors. By infusing world-class expertise at the board level, Spectral is reinforcing its commitment to scientific innovation and strategic guidance at the highest level. Quantum Computing Partnership: Ongoing negotiations with a leading Ivy League-affiliated quantum computing accelerator to expand development of Spectral's software and IP in classical-hybrid computing (integrating quantum and classical computing). This partnership is expected to fast-track the Company's R&D in quantum algorithms and intellectual property, positioning Spectral at the forefront of next-generation computing advances. Aggressive Acquisition Strategy: A focused plan to acquire small yet promising enterprise software companies and dramatically scale their performance by integrating Spectral's patents, trade secrets, and platform technologies into their products. This 'buy and build' strategy aims to rapidly grow both revenue and profit within acquired businesses by leveraging Spectral's cutting-edge innovations. Strategic Acquisitions Fueling Growth As part of this acquisition-driven growth strategy, Spectral is actively expanding its portfolio with synergistic businesses: White Label Loyalty Investment (May 2025): In May, Spectral announced a strategic $15 million investment in UK-based White Label Loyalty (WLL), a customer engagement and loyalty platform. This transaction – funded through pending Spectral's $25 million equity facility – provides significant growth capital for WLL's global expansion and product innovation. It exemplifies Spectral's approach of pairing capital with technology expertise to unlock value in high-potential software companies. Upcoming Healthcare Software Acquisition: Next month, Spectral plans to announce the acquisition of a healthcare-oriented software company, further demonstrating the versatility of its platform technologies across industries. This forthcoming acquisition will mark the Company's entry into the healthcare software sector, where Spectral's proprietary tech and IP can be applied to drive innovation and operational improvements. Through these acquisitions, Spectral intends to infuse each subsidiary with its advanced technologies – from quantum-inspired algorithms to AI-driven data analytics – to drive substantial top-line revenue growth and bottom-line efficiency gains across the board. The Company's patent-protected tools and trade secrets will enable acquired products to differentiate and scale, benefiting customers and shareholders alike. As Spectral Capital Corporation advances toward its planned Nasdaq up-listing, these transformative initiatives underscore its evolution into a high-growth technology innovator with a disciplined, acquisition-driven strategy. By enhancing governance, forming pioneering partnerships, and integrating its proprietary technologies across industries, Spectral is laying the groundwork for sustainable value creation. The Company remains committed to delivering cutting-edge solutions, driving shareholder returns, and redefining the frontier of innovation in enterprise and emerging technologies. About Spectral Capital Corporation (OTC: FCCN): Spectral Capital Corporation is a technology development and investment firm focused on identifying and supporting emerging growth companies with scalable platforms and global potential. Spectral brings a robust IP portfolio approaching 500+ patents, operational experience, strategic guidance, and long-term capital to transformative ventures in sectors such as quantum computing, artificial intelligence, and enterprise software. Founded in 2000 and headquartered in Seattle, Spectral's mission is to accelerate innovation and value creation across its portfolio. Forward-Looking Statements This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and FCCN's growth and business strategy. Words such as 'expects,' 'will,' 'intends,' 'plans,' 'believes,' 'anticipates,' 'hopes,' 'estimates,' and variations on such words and similar expressions are intended to identify forward-looking statements. Although FCCN believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of FCCN. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in FCCN's business; competitive factors in the market(s) in which FCCN operates; risks associated with operations outside the United States; and other factors listed from time to time in FCCN's filings with the Securities and Exchange Commission. FCCN expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in FCCN's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. View original content to download multimedia: SOURCE Spectral Capital Corporation
Yahoo
22-05-2025
- Business
- Yahoo
Spectral Capital Targets 500 Patents by June 30, 2025
SEATTLE, May 22, 2025 /PRNewswire/ -- Spectral Capital Corporation (OTCQB: FCCN) today announced it has completed 16 new provisional patent applications, expanding its total patent portfolio to 120. These recent filings – many at the cutting edge of machine learning and quantum computing – reinforce Spectral's aggressive innovation strategy. The company also unveiled an ambitious goal of reaching 500 patents by June 30, 2025, a target that would establish Spectral as one of the most prolific patent holders in quantum computing and ultra high-performance AI systems (including autonomous driving technologies). Key Highlights: Patent Portfolio Growth: 16 new provisional patent applications filed, bringing Spectral's total patent assets to 120. This bolsters Spectral's position at the forefront of quantum computing and AI innovation Quantum + AI Breakthroughs: Many of the latest patents focus on the intersection of quantum computing and machine learning, a convergence poised to drive ultra high-performance AI systems (from advanced cybersecurity to real-time autonomous driving, decision-making). Expanded R\&D Team: Spectral has engaged 3 veteran technologists (experts in AI and quantum research) and engaged outside patent counsel to accelerate IP development. Management believes this expanded team will help achieve 500 patentable innovations by June 30, 2025, by streamlining the path from lab discoveries to patent filings. Industry-Leading Ambition: With a 500-patent target, Spectral aims to build one of the largest intellectual property portfolios in the hybrid quantum-classical computing industry. Hitting this goal would position Spectral among the top patent holders in its sector, rivaling or surpassing many well-known quantum computing companies and AI startups in portfolio size. Pioneering Patents at the Quantum–AI Intersection Spectral's new patent applications underscore its focus on innovations that blend quantum computing with artificial intelligence. These include novel algorithms, architectures, and hardware designs that leverage quantum principles to boost AI performance. By applying quantum machine learning techniques to high-demand applications – for example, improving the real-time sensor processing and decision-making of self-driving cars – Spectral is pushing the envelope of what ultra high-performance AI systems can achieve. This concentrated effort in quantum-AI R\&D not only opens avenues for breakthrough products but also strengthens Spectral's intellectual property moat in these fast-evolving fields. "Our expanding patent portfolio underscores Spectral's commitment to pioneering next-generation solutions in quantum computing and AI," said Jenifer Osterwalder, Chief Executive Officer of Spectral Capital. "Each new patent application represents a step toward integrating quantum technology into everyday AI systems, from safer autonomous vehicles to more secure cloud computing. With 120 patents now and a clear line of sight to 500 by June 2025, we're securing our inventions and solidifying Spectral's leadership at the intersection of these transformative technologies." Team Expansion Fuels Accelerated Innovation To drive this rapid pace of innovation, Spectral has significantly strengthened its development team. The company recently engaged three seasoned experts with deep experience in quantum computing, machine learning, and high-performance computing system design. In addition, Spectral has engaged a leading patent law firm as external counsel to support the patent drafting and prosecution process. Spectral's management believes that combining new in-house expertise with outside specialized counsel will greatly increase the throughput of patentable ideas from the lab to the patent office. "By augmenting our team with proven innovators and partnering with top patent counsel, we're creating an IP engine that can deliver on our goal of 500 patents," noted Osterwalder. The company expects this bolstered capability to streamline the conversion of R\&D breakthroughs into protected intellectual property, keeping pace with Spectral's aggressive timeline. Management is confident that the expanded team can help achieve the 500-patent goal by June 30, 2025, turning Spectral's vision of an unprecedented patent portfolio into reality. Leading the Patent Race in Quantum Computing and AI With 120 patents already in its portfolio, Spectral now stands out as one of the most IP-rich startups in the quantum computing and advanced AI arena. For context, many dedicated quantum computing companies have far smaller patent libraries – for example, Rigetti Computing's portfolio numbered around 110 patents as of 2022, and IonQ's about 164 patents. Spectral's rapid progress, largely enabled by its acquisition of 104 patentable innovations last year and continued in-house development, has swiftly pushed it past several peers. If Spectral reaches its 500-patent objective, it would rival the patent holdings of long-established industry players. D-Wave Systems, one of the earliest quantum computing companies, has roughly 500 total patents in its portfolio. Even tech giants like Microsoft have on the order of 500 quantum computing patents. Spectral's mid-2025 target would put its patent count in the same league – an extraordinary feat for an emerging company. By contrast, many AI-focused startups file relatively few patents (for instance, OpenAI has filed only 6 patents globally to date), highlighting how Spectral's strategy of vigorous patent development sets it apart from the pack. This leadership in IP accumulation is more than a numbers game: it signals Spectral's determination to dominate key technological domains. The company's patents span critical areas from quantum-enhanced AI algorithms and quantum cybersecurity to autonomous driving systems and beyond. Spectral's recent strategic foray into the self-driving car sector – including a stake in a top-100 global AI autonomous driving innovator – aligns with its patent focus on high-performance AI; several new filings are expected to support breakthroughs in safer, smarter autonomous vehicles. By securing broad patent protection now, Spectral is positioning itself as a premier innovator and intellectual property leader in both quantum computing and next-generation AI, well ahead of many competitors. About Spectral Capital Corporation Spectral Capital Corporation is a publicly traded deep technology platform company at the forefront of the quantum computing revolution. The company specializes in Quantum-as-a-Service (QaaS) solutions, developing a sustainable green cloud computing infrastructure, unhackable quantum databases, and advanced quantum chip technologies. Spectral's innovations target a range of industries – from telecommunications and cybersecurity to artificial intelligence and clean energy – with a vision of delivering decentralized, ultra-secure, and scalable computing power. With its flagship Vogon™ cloud platform and a rapidly growing patent portfolio, Spectral is committed to driving the future of hybrid classical-quantum computing and enabling the next wave of high-performance AI applications. Forward-Looking Statements This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and FCCN's growth and business strategy. Words such as "expects," "will," "intends," "plans," "believes," "anticipates," "hopes," "estimates," and variations on such words and similar expressions are intended to identify forward-looking statements. Although FCCN believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of FCCN. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in FCCN's business; competitive factors in the market(s) in which FCCN operates; risks associated with operations outside the United States; and other factors listed from time to time in FCCN's filings with the Securities and Exchange Commission. FCCN expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in FCCN's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. For more information, please visit Spectral Capital. View original content to download multimedia: SOURCE Spectral Capital Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data